Newsfeeds - Spark Newswire

1 minute read

Sorrento Therapeutics Reports Its Mexican Unit Won First Tender Offer By Mexico City Municipal Gov’t. For Purchase Of Co.’s COVISTIX Tests, No Terms Disclosed

Today, 1:36 PM

Sorrento Therapeutics, Inc. (NASDAQ:SRNE, &ldquo, Sorrento&rdquo, )) announced today Sorrento Therapeutics Mexico (“Sorrento Mexico”), a Sorrento company, has won the first tender offer yesterday by the

SRNE

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:36 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

4 minute read

Stocks Hitting New 52-Week Lows Today

By Benzinga Insights

Today, 1:36 PM

On Monday morning, 60 companies achieved new lows for the year.

AGIL

1 minute read

Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects The Omicron Variant

By Benzinga Newsdesk

Today, 1:36 PM

COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and all of its major variants of concern (VoCs); COVISTIX has the potential to be a "Best-in-Class" rapid

SRNE

1 minute read

Global
News

Sorrento Therapeutics’ Subsidiary Sorrento Therapeutics Mexico Executes Second Contract For Sale Of 10M COVISTIX Tests For Mexico Market

By Benzinga Newsdesk

Today, 1:36 PM

Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )))) announced today its subsidiary, Sorrento Therapeutics Mexico ("Sorrento Mexico"), has executed a second contract with a large distributor for

SRNE

1 minute read

FDA
News

Sorrento Begins Enrollment In Phase 2 Trial Of Resiniferatoxin For The Treatment Of Pain Due To Knee Osteoarthritis

By Benzinga Newsdesk

Today, 1:36 PM

Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))) today announced that the Phase 2 clinical study of RTX for treating knee pain from osteoarthritis (OA) has begun enrollment. This study is a

SRNE

1 minute read

Sorrento Therapeutics Reports Receives Orders Of Its COVISTIX For Commercial Launch In Brazil, No Terms Disclosed

By Benzinga Newsdesk

Today, 1:36 PM

Sorrento has received orders from its logistics partner and a large diagnostic laboratory client for official commercial launch of COVISTIX™ COVID-19 Virus Rapid Antigen Detection Test in Brazil. SAN DIEGO,

SRNE

5 minute read

Sorrento Therapeutics’s Scilex Holding Co, Vicker’s Vantage Corp 1 Enter Into Letter Of Intent For Proposed Business Combination; Agreement Provides ~$1.5B Value To Scilex

By Benzinga Newsdesk

Today, 1:36 PM

Scilex Holding Company (Scilex) a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE), and Vickers Vantage Corp I (NASDAQ:VCKA) announce signing of a letter of intent for a proposed business combination, which

SRNE

2 minute read

20 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 1:36 PM

Gainers CF Acquisition Corp. VI (NASDAQ: CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble.

AEI

2 minute read

News

Sorrento Earlier Sunday, Announced Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron

By Charles Gross

Today, 1:36 PM

Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors with potent activities for both MPro and cathepsin L, a key host enzyme for SARS-CoV-2 entry into host cells, authored by Dr. Wenshe Ray Liu, professor at Texas A&M University.

SRNE